DEUTSCHE BANK AG\
BankPosition in XENE — Xenon Pharmaceuticals Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in XENE
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$9,459,957
+$933,716 QoQ
Shares Held
162,682
-14.5% QoQ
Ownership
0.168%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 55.11611610380989.ToString("F0")%
Shared 0.ToString("F0")%
None 44.88388389619011.ToString("F0")%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $2,976,719,496 across 248 Biotechnology names. XENE ranks #38 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,537,736 | $686,660,626 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
625,388 | $483,199,777 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
761,464 | $251,945,590 | |
| 4 | INCY |
Incyte Corp
|
1,264,195 | $118,986,027 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,453,303 | $117,684,942 | |
| 6 | ARGX |
Argenx SE
|
139,381 | $101,782,972 | |
| 7 | INSM |
INSMED Inc
|
562,474 | $91,975,745 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
306,111 | $61,115,059 |
All Filings in XENE
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,459,957 | 162,682 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $8,526,241 | 190,233 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $4,534,981 | 112,951 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,271,913 | 104,534 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,802,004 | 53,711 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $2,105,471 | 53,711 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $2,114,602 | 53,711 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $2,094,191 | 53,711 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $1,666,508 | 38,711 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $114,919 | 2,495 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $85,229 | 2,495 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $116,808 | 3,034 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $89,296 | 2,495 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $98,377 | 2,495 | Shares | Defined | 2023-02-13 | |
| 2021-09-30 | $122,041 | 7,987 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $986 | 53 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $1,575 | 88 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $469,397 | 30,520 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $337,291 | 30,469 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $382,081 | 30,469 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,078,207 | 95,080 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||